SAVIENT PHARMACEUTICALS INC 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Oct 17, 2013
Insider Transaction Report
Form 4
YACHMETZ PHILIP K
SVP, General Counsel
Transactions
- Sale
Common Stock
2013-10-15$0.10/sh−40,000$4,000→ 203,956 total - Sale
Common Stock
2013-10-15$0.09/sh−10,000$916→ 90,545 total - Sale
Common Stock
2013-10-15$0.10/sh−19,745$1,921→ 263,956 total - Sale
Common Stock
2013-10-15$0.09/sh−20,000$1,828→ 243,956 total - Sale
Common Stock
2013-10-15$0.10/sh−20,000$2,030→ 283,701 total - Sale
Common Stock
2013-10-15$0.10/sh−50,000$4,895→ 153,956 total - Sale
Common Stock
2013-10-15$0.10/sh−53,411$5,245→ 100,545 total